Traws Pharma, Inc. (TRAW) ownership: Top institutional holder: ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.34M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 730000.00 | $1.34M | 2026-03-31 |
| Ikarian Capital, LLC | 678142.00 | $1.24M | 2026-03-31 |
| ORBIMED ADVISORS LLC | 605531.00 | $1.11M | 2026-03-31 |
| Squadron Capital Management LLC | 511714.00 | $936437.00 | 2026-03-31 |
| Dauntless Investment Group, LLC | 416998.00 | $763106.00 | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 194536.00 | $356001.00 | 2026-03-31 |
| ADAR1 Capital Management, LLC | 154098.00 | $281999.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 77103.00 | $141100.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-07-09 | |
| Sell | null | 2026-07-09 | |
| Sell | null | 2026-07-09 | |
| Sell | null | 2026-07-09 | |
| Sell | null | 2026-07-09 | |
| Sell | null | 2026-07-09 | |
| Sell | null | 2026-07-09 | |
| Sell | null | 2026-07-09 |
Back to TRAW overview · TRAW earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.